This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.

NEW YORK, April 24, 2013 /PRNewswire/ -- Howard P. Milstein, Chairman of American Skin Association (ASA), announced that J. Michael Pearson, Chairman and CEO of Valeant Pharmaceuticals International, Inc., has become a member of the ASA Board of Directors.

ASA's main mission is to advance research, champion skin health and drive public awareness regarding skin disease and melanoma/skin cancer. Through its national program of grants and awards, ASA has committed approximately $9 million to underwriting research by a new generation of scientists trained in dermatology and dedicated to overcoming the most serious forms of skin disease.

" Mike Pearson brings a tremendous wealth of experience to the Board. I look forward to working with him as we continue funding research, educating future generations on skin health and furthering the goal of defeating melanoma, skin cancer, and other skin diseases," said Howard P. Milstein.

"I am honored to become a part of ASA," Mike Pearson said. "Their efforts on behalf of skin disease and skin cancer have had a tremendous effect on increasing public awareness and their commitment to dermatology research has been a key driver in encouraging earlier diagnoses and new therapies. I look forward to working with the rest of the Board of Directors upholding and promoting the ASA's mission."

ASA also announced that Ryan Weldon, Executive Vice President and Company Group Chairman of the U.S. Dermatology Operations at Valeant Pharmaceuticals International, Inc., has become a member of its Education Council.  Weldon was appointed as an Executive Officer at Valeant in December 2012. Prior to that, he served as Vice President and General Manager of Aesthetics and General Manager of U.S. Neurology and Other at Valeant.

"Many of Valeant's acquisitions were once, or still are, some of the world's leading brands, transforming Valeant into one of the world's most important suppliers of dermatology drugs," said Humberto C. Antunes, President and CEO of Galderma and Co-Chair of ASA's Education Council.

ABOUT AMERICAN SKIN ASSOCIATIONLed by patients, families and their advocates working with the nation's foremost physicians and scientists, American Skin Association has evolved into an increasingly influential leader in efforts to defeat melanoma and other serious forms of skin disease. For over two decades, its mission has remained to advance research, champion skin health - particularly among young people, and raise public awareness about skin cancer and disease. For more information, visit www.americanskin.org.

SOURCE American Skin Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs